(Q84773235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

Alexander M. M. Eggermont

8

object named as

Alexander M M Eggermont

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Herman van Dekken

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Jill A. van der Zee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Timo L. M. ten Hagen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Wim C. J. Hop

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Bilyana M. Dicheva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Ann L. B. Seynhaeve

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Gerben A. Koning

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Alexander M. M. Eggermont

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

Casper H. J. van Eijck

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724141

19 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20724141

19 June 2024

publication date

17 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 February 2020

https://api.elsevier.com/content/article/PII:S0959804910007021?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

https://api.elsevier.com/content/article/PII:S0959804910007021?httpAccept=text/plain

19 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

European Journal of Cancer

19 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

3393-3399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

10 February 2020

cites work

Cancer statistics, 2009

1 reference

28 May 2022

The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis

2

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Past and future of pancreas cancer: are we ready to move forward together?

19 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

On the presence of two new high mobility group‐like proteins in HeLa S3 cells

19 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Roles of HMGA proteins in cancer

19 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Molecular biology of HMGA proteins: hubs of nuclear function

19 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y

19 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor

19 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus

19 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization

19 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

19 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias

19 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma

19 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins

19 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Expression of the HMGI(Y) gene in human colorectal cancer.

19 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.

19 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGI(Y) gene expression in colorectal cancer: comparison with some histological typing, grading, and clinical staging

19 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix

19 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins

19 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas

19 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma

19 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Expression of HMGI(Y) associated with malignant phenotype of human gastric tissue

19 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas

19 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression

19 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.

19 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Increased expression of high mobility group A proteins in lung cancer.

19 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

19 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma

19 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

High-mobility group A1 proteins are overexpressed in human leukaemias

19 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade

19 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours

19 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status

19 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

19 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models

19 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma

19 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells

19 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma

19 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial

19 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

19 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

HMGA1 protein expression in familial breast carcinoma patients

19 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EJCA.2010.07.024

19 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20724141%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference